荔枝胚胎败育与酚类抑制物质的关系

在荔枝 (LitchichinensisSonn .)胚胎败育发生期 ,以系统溶剂法从正常或败育胚珠中初步提取酚类抑制物质 ,通过TLC分离与纯化 ,用GC MS联用仪进一步分离鉴定 ,并以标准品核对。试验首次从荔枝胚珠中分离鉴定出酚类抑制物质对羟基苯甲酸 (p_HBA)。生物活性测定表明 ,p_HBA是一种很强的生长抑制物质。在败育胚珠中其含量及IAA氧化酶活性均显著高于正常胚珠 ,IAA水平则明显低于正常胚珠 (P <0 .0 1)。因此认为 ,p_HBA参与了荔枝胚胎发育的调节 ,高含量的p_HBA是通过促进IAA侧链的氧化并影响促进和抑制生长的物质之间的平衡而导致荔枝胚胎的败育     

油菜每角果粒数差异的细胞学基础和分子机理

每角果粒数在油菜不同品种、品系或其他种质资源之间存在着较大的变异.该性状的研究对于利用优良变异提高油菜产量具有重要意义.对多个DH系和常规栽培种进行分析,研究了油菜每角果粒数差异形成的细胞学基础和分子机理.结果表明,部分胚珠原基在发育过程中败育而不能最终形成成熟的种子,正常发育胚珠百分比是每角果粒数差异的重要决定因素.细胞学分析确定了胚珠败育发生的时期是在大孢子退化之后,单核期配子体形成之前.研究结果还显示,油菜胚珠败育率的差异可能是由BRs-BRI1信号途径调控水平的差异所致.     

荔枝胚胎败育与酚类抑制物质的关系

在荔枝(Litchi chinensis Sonn.)胚胎败育发生期,以系统溶剂法从正常或败育胚珠中初步提取酚类抑制物质,通过TLC分离与纯化,用GC-MS联用仪进一步分离鉴定,并以标准品核对.试验首次从荔枝胚珠中分离鉴定出酚类抑制物质对羟基苯甲酸(p-HBA).生物活性测定表明,p-HBA是一种很强的生长抑制物质.在败育胚珠中其含量及IAA氧化酶活性均显著高于正常胚珠,IAA水平则明显低于正常胚珠(P<0.01).因此认为,p-HBA参与了荔枝胚胎发育的调节,高含量的p-HBA是通过促进IAA侧链的氧化并影响促进和抑制生长的物质之间的平衡而导致荔枝胚胎的败育.     

醮核荔枝胚胎发育相关蛋白质的分离及初步鉴定

通过二维聚丙烯酰胺凝胶电泳以及计算机辅助的图像分析技术,对荔枝开花后40d的正常与败育胚蛋白质图谱进行初步分析。结果表明,100个蛋白质点在表达丰度上有明显差异;选择仅在正常发育胚胎胶上表达的蛋白点15个和仅在败育胚胎胶上表达的蛋白点50个,进行基质辅助激光解吸附电离飞行时间质谱（MALDI—TOFMASS）分析,鉴定出9个与胚发育相关的蛋白,这些蛋白可能参与了胚败育的调节和控制。     

焦核与大核龙眼雌配子体发育、授粉受精及早期胚胎发育的比较研究

利用人工授粉,采用压片法对大核龙眼‘九月乌’和焦核龙眼‘闽焦64-1’、‘闽焦64-2’、‘白核’等的自交与杂交后花粉管的生长特性进行研究,同时应用常规石蜡切片技术对大核与焦核龙眼的雌配子体以及合子胚早期发育进行观察。结果表明,龙眼胚珠在单核胚囊形成前就开始败育,且焦核品种(系)的败育率显著高于大核品种。不同亲本组合的授粉率存在差异,所有授粉组合在授粉36～48 h后均能观察到1个花粉管生长并进入胚囊受精。焦核品种(系)的胚胎在谢花后10 d开始败育,且败育率明显高于大核品种。受精是龙眼子房发育的首要条件,胚珠败育的雌蕊在谢花后10 d不膨大,不能发育形成焦核果实。谢花后10～30 d的早期胚胎败育是形成焦核龙眼的主要原因。焦核品种‘白核’胚乳具有成胚能力。约有24%的‘闽焦64-1’胚珠在胚胎发育过程中,其助细胞、合点端细胞及胚乳发生异常,这可能与早期胚胎败育有关。     

一串红胚胎发育过程中多胺含量的变化

选取发育正常和败育一串红(Saliva splendens)5个不同时期的胚胎,分别提取、测定多胺(精胺、亚精胺、腐胺与尸胺)的含量变化.通过比较一串红胚胎发育不同阶段多胺物质的变化规律,探讨多胺在一串红胚胎发育中的生理作用.结果表明,一串红的胚胎败育和胚珠中较低的多胺含量及其在发育进程中较大的降幅有关;在盛花期,胚胎发育的关键时期,正常胚珠中哑精胺的含量有一个明显的峰值,而败育的胚珠中则无,这表明亚精胺含量变化在胚胎发育中起关键调节作用.     

两种互逆资源梯度影响下刺叶锦鸡儿的种子选择性败育格局

种子的选择性败育在被子植物中普遍存在,开展结籽格局及其影响因素的研究有助于深入了解种子的形成机制及多样化的生殖对策。以刺叶锦鸡儿Caragana acanthophylla为材料,通过传粉过程、胚珠发育动态和资源分配状况的研究,以探讨种子的选择性败育格局及相关影响因素。结果显示：(1)刺叶锦鸡儿具高度自交不亲和性,为泛化的传粉系统,蜂类是主要的传粉者。自然状态的结实率为(86.00±4.96)%,不存在传粉限制,但受精具明显的时间效应。(2)刺叶锦鸡儿单花期4—5d,每朵花有(14.00±0.14)粒胚珠。胚珠的发育从荚果顶部开始,其中,开花后第3天荚果顶部胚珠开始膨大;第11天绝大多数胚珠出现了膨大,此时,在荚果基部的胚珠开始败育,随后荚果顶端受精后的胚珠也出现败育,最终仅荚果中部形成2—3粒种子。其结籽格局为成熟荚果中部胚珠,而败育荚果顶部和基部胚珠的选择性败育类型。(3)受微地形影响,居群内开花植株具斑块分布,对较少开花植株通过添加水肥进行资源调控后,结籽率显著提高,说明在种子形成过程中存在资源限制。综上所述,受精顺序和资源限制两个互逆的资源梯度决定了刺叶锦鸡儿的结籽格局。其中,...     

荔枝胚珠中多胺含量变化与胚胎发育的关系

荔枝胚胎发育与胚珠中３种多胺（ＰＡｓ）含量及其比例变化关系密切。试验结果表明：正常发育的胚珠中腐胺（Ｐｕｔ）、亚精胺（Ｓｐｄ）和精胺（Ｓｐｍ）的含量在胚胎发育的各个阶段均高于败育胚珠,并在花后７ｄ即达到最高值,其中Ｐｕｔ的含量最高,随后都呈下降趋势。但正常胚珠中Ｓｐｍ含量在花后２２至３１ｄ（球形胚至心形胚发育阶段）均有所回升,而败育胚珠无此现象。败育胚珠中的Ｓｐｄ和Ｓｐｍ在胚胎败育期的下降速度显著     

鹅掌楸雌配子体败育对生殖的影响

胚珠和雌配子体败育是限制鹅掌楸生殖成功的一个重要因素。中国东部和西部鹅掌楸种群在雌配子体发育的各阶段上的败育程度有差异,以西部种群的发育较好。西部分布区较合适的生境促进了胚囊的发育,一定温度和湿度的环境可以活化珠心细胞输送营养物质供给雌配子体发育,提高受精和结籽的能力     

拟南芥温度诱导脂质运载蛋白TIL1参与雌配子体发育

雌配子体的正常发育是种子形成的前提条件之一,拟南芥温度诱导的脂质运载蛋白编码基因TIL1突变使胚珠败育,结实率下降明显。基因表达分析表明T-DNA插入使得TIL1基因敲除,突变体TIL1基因功能缺失;互交实验、Alexander染色、花粉离体培养和胚珠透明实验结果表明till-1突变体雄配子体发育正常、雌配子体胚囊发育有缺陷;通过遗传互补实验证明外源克隆的TIL1基因能恢复突变体的败育表型,并确定了TIL1基因主要在胚珠的胚囊中表达。实验结果表明TIL1基因参与了植物雌配子体发育这一重要的生理过程。     

利用EST序列构建Mascot本地数据库

对蛋白质质谱数据进行数据库比对和鉴定是蛋白质组学研究技术中的一个重要步骤。由于公共数据库蛋白质数据信息不全,有些蛋白质质谱数据无法得到有效的鉴定。而利用相关物种的EST序列构建专门的质谱数据库则可以增加鉴定未知蛋白的几率。本文介绍了利用EST序列构建Mascot本地数据库的具体方法和步骤,扩展了Mascot检索引擎对蛋白质质谱数据的鉴定范围,从数据库层面提高了对未知蛋白的鉴别几率,为蛋白质组学研究提供了一种较为实用的生物信息学分析技术。     

Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry

Hyperphosphorylated tau is an integral part of the neurofibrillary tangles that form within neuronal cell bodies, and tau protein kinase II is reported to play a role in the pathogenesis of Alzheimer's disease. Recently, we reported that tau protein kinase II (cdk5/p20)-phosphorylated human tau inhibits microtubule assembly, and tau protein kinase II (cdk5/p20) phosphorylation of microtubule-associated tau results in dissociation of phosphorylated tau from the microtubules and tubulin depolymerization. In the studies reported here, a combination of mass spectrometric techniques was used to study the phosphorylation of human recombinant tau by recombinant tau protein kinase II (cdk5/p20) in vitro. The extent of phosphorylation was determined by measuring the molecular mass of phosphorylated tau using mass spectrometry. Reaction of human recombinant tau with tau protein kinase II (cdk5/p20) resulted in the formation of two major species containing either five or six phosphate groups. The specific amino acid residues phosphorylated were determined by analyzing tryptic peptides by tandem mass spectrometry via either MALDI/TOF post-source decay or by electrospray tandem mass spectrometry. Based on these experiments, we conclude that tau protein kinase II (cdk5/p20) can phosphorylate human tau at Thr(181), Thr(205), Thr(212), Thr(217), Ser(396) and Ser(404).     

现代质谱技术在蛋白质组学中的应用及其最新进展

简述了蛋白质组学的概念、内容和意义,重点综述了现代质谱技术在蛋白质组学中的应用,主要包括蛋白质和肽段的鉴定和定量、蛋白质翻译后修饰的鉴定和蛋白质间相互作用的检测等。随着新的高质量精确度、分辨率、灵敏度和通量质谱仪的出现,现代质谱技术在蛋白质组学中的应用将越来越广泛,并给蛋白质组学研究带来新的机遇。     

基于质谱技术的蛋白质互作研究进展

蛋白质作为生命活动的执行者,其功能往往体现在与其他蛋白质的相互作用中,研究蛋白-蛋白相互作用对于人们深入了解和预防传染病、靶向治疗多基因疾病、阐明蛋白质的分子作用机制及各种复杂的生命现象具有重要意义。目前,有多种技术被用来研究蛋白间的相互作用,研究难点在于实时捕获瞬时或弱蛋白质间的相互作用,质谱技术（mass spectrometry, MS）可在某种程度上解决该难点。由于质谱技术可研究简单的蛋白质复合物再到大规模的蛋白质组实验,基于质谱技术研究蛋白质间相互作用被越来越多地应用于科学研究中。综述了蛋白质间相互作用检测方法的研究进展,重点介绍了氢氘交换质谱法和化学交联质谱法研究蛋白质间相互作用的优缺点及其应用,最后对基于质谱技术研究蛋白质间相互作用进行了总结与展望,以期为深入开展相关研究提供借鉴。     

Mass spectrometry-based immunoassays for the next phase of clinical applications

Recent applications of affinity mass spectrometry into clinical laboratories brought a renewed interest in immunoaffinity mass spectrometry as a more specific affinity method capable of selectively targeting and studying protein biomarkers. In mass spectrometry-based immunoassays, proteins are affinity retrieved from biological samples via surface-immobilized antibodies, and are then detected via mass spectrometric analysis. The assays benefit from dual specificity, which is brought about by the affinity of the antibody and the protein mass readout. The mass spectrometry aspect of the assays enables single-step detection of protein isoforms and their individual quantification. This review offers a comprehensive review of mass spectrometry-based immunoassays, from historical perspectives in the development of the immunoaffinity mass spectrometry, to current applications of the assays in clinical and population proteomic endeavors. Described in more detail are two types of mass spectrometry-based immunoassays, one of which incorporates surface plasmon resonance detection for protein quantification. All mass spectrometry-based immunoassays offer high-throughput targeted protein investigation, with clear implications in clinical research, encompassing biomarker discovery and validation, and in diagnostic settings as the next-generation immunoassays.     

Proteomics without polyacrylamide: qualitative and quantitative uses of tandem mass spectrometry in proteome analysis

Proteomics can be thought of as an attempt to understand the information encoded in genomic sequences from the perspective of proteins; i.e. the structure, function and regulation of biological processes at the protein level. In practice it stands in stark contrast to the hypothesis-driven serial approach practiced in the last century that was so successful for protein chemists and is built on the basic understanding of protein physicochemical properties developed during that era. Proteomics attempts to study biological processes comprehensively or globally by systematic parallel analysis of proteins expressed in a cell. While there are many analytical techniques in use and under development in proteomics, mass spectrometry is currently one of the field's most important discovery-based tools. This article will review some of the current approaches for qualitative and quantitative uses of tandem mass spectrometry in the field of proteomics specifically avoiding a discussion of the use of gel electrophoresis prior to mass spectrometry. Electronic Publication     

cAMP induced alterations of Chinese hamster ovary cells monitored by mass spectrometry

Chinese Hamster Ovary fibroblasts (CHO-K1) have shown different protein contents when undergoing differentiation by 3',5'-cyclic adenosine monophosphate (cAMP), which is known to induce reverse transformation (RT) from malignancy to fibroblast-like characteristics. The mass spectrometry (MS) investigation here reported about the behavior of CHO-K1 cells before and after exposure to cAMP reveals a change in the composition of nuclear proteins associated to an inhibition of the protein expression. Possible implications of this finding on the control of cell reverse transformation are discussed.     

Isotope-differentiated binding energy shift tags (IDBEST™) for improved targeted biomarker discovery and validation

Mass spectrometry has proved to be an important tool for protein biomarker discovery, identification and characterization. However, global proteomic profiling strategies often fail to identify known low-abundance biomarkers as a result of the limited dynamic range of mass spectrometry (two to three orders of magnitude) compared with the large dynamic range of protein concentrations in biologic fluids (11 to 12 orders of magnitude for serum). In addition, the number of peptides generated in such methods vastly overwhelms the resolution capacity of mass spectrometers, requiring extensive sample clean-up (e.g., affinity tag, retentate chromatography and/or high-performance liquid chromatography) before mass spectrometry analysis. Baiting and affinity pre-enrichment strategies, which overcome the dynamic range and sample complexity issues of global proteomic strategies, are very difficult to couple to mass spectrometry. This is due to the fact that it is nearly impossible to sort target peptides from those of the bait since there will be many cases of isobaric peptides. IDBEST? (Target Discovery, Inc.) is a new tagging strategy that enables such pre-enrichment of specific proteins or protein classes as the resulting tagged peptides are distinguishable from those of the bait by a mass defect shift of approximately 0.1 atomic mass units. The special characteristics of these tags allow: resolution of tagged peptides from untagged peptides through incorporation of a mass defect element; high-precision quantitation of up- and downregulation by using stable isotope versions of the same tag; and potential analysis of protein isoforms through more complete peptide coverage from the proteins of interest.     

中药新药保肝作用的研究进展

肝脏作为代谢器官,在人体内发挥着重要作用。随着肝病的发病率逐年上升,如何有效的保肝护肝已成为医学界和药学界共同面一临的巨大挑战之一。化学药物在治疗肝病的同时常常伴随各种毒副作用甚至更进一步的肝损伤,而中药凭借其安全性和有效性的优势在肝病治疗领域受到越来越多的重视。中药护肝已有悠久的历史,近年来随着技术的进步,更多更好的新型中药逐步上市,相关研究不断增多。本文将就这些研究成果进行阐述。     

The Plant PTM Viewer,a central resource for exploring plant protein modifications

Post‐translational modifications (PTMs) of proteins are central in any kind of cellular signaling. Modern mass spectrometry technologies enable comprehensive identification and quantification of various PTMs. Given the increased numbers and types of mapped protein modifications, a database is necessary that simultaneously integrates and compares site‐specific information for different PTMs, especially in plants for which the available PTM data are poorly catalogued. Here, we present the Plant PTM Viewer (http://www.psb.ugent.be/PlantPTMViewer), an integrative PTM resource that comprises approximately 370 000 PTM sites for 19 types of protein modifications in plant proteins from five different species. The Plant PTM Viewer provides the user with a protein sequence overview in which the experimentally evidenced PTMs are highlighted together with an estimate of the confidence by which the modified peptides and, if possible, the actual modification sites were identified and with functional protein domains or active site residues. The PTM sequence search tool can query PTM combinations in specific protein sequences, whereas the PTM BLAST tool searches for modified protein sequences to detect conserved PTMs in homologous sequences. Taken together, these tools help to assume the role and potential interplay of PTMs in specific proteins or within a broader systems biology context. The Plant PTM Viewer is an open repository that allows the submission of mass spectrometry‐based PTM data to remain at pace with future PTM plant studies.